FDA accepts Roche’s new drug application for Giredestrant in advanced breast cancer
FDA greenlights first all-oral, fixed-duration combo therapy for untreated CLL patients
Zeus Hygia and Patch House Labs join forces to take nutraceuticals beyond the pill
Lonza scales bioconjugate innovation through enhanced synthesis offering
Johnson & Johnson bags FDA nod for monthly RYBREVANT FASPRO dosing in advanced lung cancer
BIOEMTECH & NorthStar strike deal to boost access to critical Actinium-225 for preclinical research
Novartis bags Phase III win for Remibrutinib in chronic inducible urticaria
Catalent and S.Biomedics join forces to advance groundbreaking Parkinson’s therapy
Evinova teams up with Astellas, AstraZeneca & Bristol Myers Squibb to supercharge clinical trials with AI
GSK’s Exdensur wins EU nod for severe asthma
If approved, TEV-'749 could help address a significant unmet need in available schizophrenia treatment options by addressing the lack of viable long-acting olanzapine formulations
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
